The biowarfare aspects of Q fever

Joshua D. Hartzell, Kerry Wilson, Larry I. Lutwick*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


The zoonotic bacterium Coxiella burnetii is considered a category B bioterrorism agent related to the organism's ease of manufacture, environmental stability, readiness of aerosol transmission over long distances and the ability for very small numbers of organisms to cause disease in human. This chapter will review the history of the agent in biological warfare experimentation including the US Military's Whitecoat Program and the clinical aspects of the infection in the biological warfare setting. As an example of a potential biowarfare agent, the general management of mass casualty settings in the face of an attack will be described and the chemoprophylaxis of Q fever and the use of a vaccine for humans for prevention will be discussed.

Original languageEnglish
Title of host publicationThe Principles and Practice of Q Fever
Subtitle of host publicationThe One Health Paradigm
PublisherNova Science Publishers, Inc.
Number of pages11
ISBN (Electronic)9781536108682
ISBN (Print)9781536108514
StatePublished - 1 Jan 2017
Externally publishedYes


  • Antimicrobials
  • Biowarfare
  • Clinical symptoms
  • Immune response
  • US military's whitecoat program


Dive into the research topics of 'The biowarfare aspects of Q fever'. Together they form a unique fingerprint.

Cite this